litlas
Log inCreate account

K. Borch‐Johnsen

Active 1984–2010

Also published as
K. Borch-Johnsen · K Borch-Johnsen
73
Papers
21,543
Citations
72
h-index
73
i10-index

Citations

Citations per year for K. Borch‐Johnsen1966: 4 citations1972: 1 citations1984: 2 citations1985: 5 citations1986: 9 citations1987: 22 citations1988: 23 citations1989: 30 citations1990: 18 citations1991: 26 citations1992: 52 citations1993: 34 citations1994: 29 citations1995: 36 citations1996: 48 citations1997: 39 citations1998: 65 citations1999: 79 citations2000: 105 citations2001: 107 citations2002: 133 citations2003: 171 citations2004: 239 citations2005: 217 citations2006: 247 citations2007: 203 citations2008: 187 citations2009: 198 citations2010: 196 citations2011: 213 citations2012: 165 citations2013: 215 citations2014: 234 citations2015: 222 citations2016: 169 citations2017: 140 citations2018: 99 citations2019: 336 citations2020: 296 citations2021: 226 citations2022: 151 citations2023: 105 citations2024: 146 citations2025: 52 citations1967–1971: no citations, so these years are not shown1973–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,671 citing papers, 20.3% of this breakdownUnited Kingdom: 778 citing papers, 9.4% of this breakdownDenmark: 558 citing papers, 6.7% of this breakdownItaly: 445 citing papers, 5.4% of this breakdownGermany: 382 citing papers, 4.6% of this breakdownSweden: 355 citing papers, 4.3% of this breakdownNetherlands: 329 citing papers, 4% of this breakdownAustralia: 296 citing papers, 3.6% of this breakdownCanada: 279 citing papers, 3.4% of this breakdownChina: 263 citing papers, 3.2% of this breakdownFrance: 238 citing papers, 2.9% of this breakdownSpain: 220 citing papers, 2.7% of this breakdown
0%20.3%Other 29.5%

Institutions

Fields

  • Medicine78.3%
  • Biochemistry, Genetics and Molecular Biology14.1%
  • Nursing1.5%
  • Health Professions1.3%
  • Neuroscience0.9%
  • Environmental Science0.6%
  • Other3.3%

Topics

  • Diabetes, Cardiovascular Risks, and Lipoproteins6.9%
  • Diabetes Management and Research4.2%
  • Chronic Kidney Disease and Diabetes3.7%
  • Diabetes Treatment and Management3.6%
  • Diabetes and associated disorders3%
  • Metabolism, Diabetes, and Cancer2.8%
  • Other75.8%

Coauthors

All papers

Open in search
  1. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

    Authors: Authors/Task Force Members, Ian D. Graham, Dan Atar, K. Borch‐Johnsen, G. Boysen, Gunilla Burell, Renata Cífková, Jean Dallongeville, Guy De Backer, S. Ebrahim, B. Gjelsvik, Christoph Herrmann‐Lingen, A. Hoes, Steve E. Humphries, M Knapton, Joep Perk, Silvia G. Priori, K Pyörälä, Z. Reiner, Luís M. Ruilope, Susana Sans-Menéndez, Wilma Scholte op Reimer, Peter L. Weissberg, D. Wood, John Yarnell, J. L. Zamorano, Other experts who contributed to parts of the guidelines:, Edmond Walma, Tanya Fitzgerald, Marie Therese Cooney, A. Dudina, Alec Vahanian, A. John Camm, R. De Caterina, V. Dean, Kenneth Dickstein, Christian Funck‐Brentano, G. Filippatos, Irene Hellemans, S. D. Kristensen, Keith McGregor, U Sechtem, Sigmund Silber, Michał Tendera, P. Widimsky, José Luis Zamorano, Document reviewers:, Irene Hellemans, Attila Altiner, Enzo Bonora, Paul N. Durrington, R. Fagard, Simona Giampaoli, Harry Hemingway, Jan Håkansson, Sverre E. Kjeldsen, M. Lytken Larsen, G. Mancia, Athanasios Manolis, Kristina Orth‐Gomér, Terje Pedersen, Mike Rayner, L Rydén, Mario R. Sammut, Neil Schneiderman, Anton F. H. Stalenhoef, Lâle Tokgözoğlu, Olov Wiklund, Antonis Zampelas - European Heart Journal 2007 cited by 3,758

  2. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

    Authors: J Jacobs, M Sena, N Fox, A Andersen, J Christiansen, J Andersen, S Kreiner, T Deckert, Group Research, Group Research, Group Research, Group Research, M Stevens, M Edwards, Avm Foster, P Watkins, E Feldman, M Stevens, P Thomas, M Brown, N Canal, D Greene, Group Research, K Abt, D Cox, B Turnbull, D Finkelstein, J Lachin, L Wei, S Zeger, K Liang, N Laird, J Ware, R Klein, Bek Klein, S Moss, M Davis, D Demets, R Klein, S Moss, T Orchard, J Dorman, R Maser, D Becker, A Drash, D Ellis, R Laporte, L Kuller, A Krolewski, E Kosinski, J Warram, O Leland, E Busick, A Asmal, L Rand, A Christlieb, R Bradley, C Kahn, T Jensen, K Borch-Johnsen, A Kofoed-Enevoldsen, T Deckert, T Deckert, B Feldt-Rasmussen, K Borch-Johnsen, T Jensen, A Kofoed-Enevoldsen, B Fisher, G Gillen, Gbm Lindop, H Dargie, B Frier, M Koistinen, M Gerson, J Khoury, V Hertzberg, E Fischer, R Scott, G Persson, K Jensen-Urstad, P Reichard, J Rosfors, Lel Lindblad, M Jensen-Urstand, M Stern, E Boyko, G Reiber, P Bennett, G Riccardi, O Vaccaro, A Riveliese, G Romano, V Cambri, P Rubba, P Pauciullo, G Greco, L Iovine, M Mancini, S Carter, T Deckert and 76 more - Diabetes Care 1999 cited by 653

  3. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

    Authors: Kristine Færch, K. Borch‐Johnsen, Jens J. Holst, Allan Vaag - Diabetologia 2009 cited by 248

  4. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study

    Authors: Ulrik Becker, A Deis, Thorkild I. A. Sørensen, Morten Grønbæk, K. Borch‐Johnsen, Charlotte Müller, Peter Schnohr, Gorm Boje Jensen - Hepatology 1996 cited by 824

  5. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

    Authors: Jesper Eugen‐Olsen, Ove Andersen, Allan Linneberg, Steen Ladelund, Tine W. Hansen, Anne Langkilde, Janne Petersen, Tomasz Pielak, Line Møller, Jørgen Jeppesen, Stig Lyngbæk, Mogens Fenger, Michael Hecht Olsen, Per Hildebrandt, K. Borch‐Johnsen, Torben Jørgensen, Steen B. Haugaard - Journal of Internal Medicine 2010 cited by 372

  6. Albuminuria reflects widespread vascular damage

    Authors: T. Deckert, Bo Feldt‐Rasmussen, K. Borch‐Johnsen, T. Jensen, Allan Kofoed‐Enevoldsen - Diabetologia 1989 cited by 1,404

  7. Cancer Incidence in a Population-Based Cohort of Patients Hospitalized With Diabetes Mellitus in Denmark

    Authors: Louise Wideroff, Gloria Gridley, W.- H. Chow, M. Linet, Lene Mellemkjær, Jørgen H. Olsen, S. Keehn, K. Borch-Johnsen - JNCI Journal of the National Cancer Institute 1997 cited by 630

  8. The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study

    Authors: Ulla Toft, Lis Kristoffersen, Cathrine Juel Lau, K. Borch‐Johnsen, Torben Jørgensen - European Journal of Clinical Nutrition 2006 cited by 199

  9. European guidelines on cardiovascular disease prevention in clinical practice

    Authors: De Backer G, E Ambrosioni, K. Borch‐Johnsen, Carlos Brotons, Renata Cífková, Jean Dallongeville, S Ebrahim, Ole Færgeman, Ian D. Graham, Giuseppe Mancia, Cats Vm, Kristina Orth‐Gomér, Joep Perk, Kalevi Pyörälà, Ródicio Jl, S Sans, Vedat Sansoy, U Sechtem, Sigmund Silber, Troels Thomsen, David M. Wood - Atherosclerosis 2003 cited by 495

  10. The Danish National Diabetes Register: trends in incidence, prevalence and mortality

    Authors: Bendix Carstensen, Jette Kolding Kristensen, PD. Ottosen, K. Borch‐Johnsen, on behalf of the steering group of the National Diabetes Register - Diabetologia 2008 cited by 308

  11. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts

    Authors: Qing Qiao, Tomoko Nakagami, J. Tuomilehto, K. Borch‐Johnsen, Beverley Balkau, Yasuhiko Iwamoto, Naoko Tajima - Diabetologia 2000 cited by 204

  12. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes

    Authors: Y. H. Hamid, C S Rose, Søren A. Urhammer, C. Gl�mer, Runa Nols�e, O. P. Kristiansen, Thomas Mandrup‐Poulsen, K. Borch‐Johnsen, Torben Jørgensen, Torben Hansen, Oluf Pedersen - Diabetologia 2005 cited by 160

  13. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study

    Authors: Kristine Færch, K. Borch‐Johnsen, Allan Vaag, Torben Jørgensen, Daniel R. Witte - Diabetologia 2010 cited by 128

  14. Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people

    Authors: Trine Welløv Boesgaard, Niels Grarup, Torben Jørgensen, K. Borch‐Johnsen, Torben Hansen, Oluf Pedersen - Diabetologia 2010 cited by 102

  15. Inuit health in Greenland: a population survey of life style and disease in Greenland and among Inuit living in Denmark

    Authors: Peter Bjerregaard, Tim Curtis, K. Borch‐Johnsen, Gert Mulvad, Ulrik Becker, Stig Andersen, Vibeke Backer - International Journal of Circumpolar Health 2003 cited by 95

  16. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

    Authors: K. Borch‐Johnsen, Svend Kreiner - BMJ 1987 cited by 558

  17. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

    Authors: M.-A. Gall, Philip Hougaard, K. Borch‐Johnsen, Hans‐Henrik Parving - BMJ 1997 cited by 444

  18. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study

    Authors: Peter Rossing, P. Hougaard, K. Borch‐Johnsen, Hans-Henrik Parving - BMJ 1996 cited by 434

  19. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening

    Authors: GRuttenfor the ADDITION Study Group, T. Lauritzen, Simon J. Griffin, K. Borch‐Johnsen, NicholasJ. Wareham, BHR Wolffenbuttel - International Journal of Obesity 2000 cited by 250

  20. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland

    Authors: Jaakko Tuomilehto, K. Borch‐Johnsen, Anu Molarius, Tom Forsén, Daiva Rastenytė, Cristina Sarti, Antti Reunanen - Diabetologia 1998 cited by 225

  21. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes

    Authors: Thomas Sparsø, Gary L. Andersen, Trine Nielsen, Kristoffer Sølvsten Burgdorf, Anette P. Gjesing, Arne L. Nielsen, Anders Albrechtsen, S. Rasmussen, Torben Jørgensen, K. Borch‐Johnsen, Annelli Sandbæk, T. Lauritzen, Sten Madsbad, Torben Hansen, Oluf Pedersen - Diabetologia 2007 cited by 172

  22. A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit

    Authors: Marit E. Jørgensen, K. Borch‐Johnsen, Peter Bjerregaard - Diabetologia 2008 cited by 101

  23. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

    Authors: K. Borch‐Johnsen, Andrew Neil, Beverley Balkau, Signe Holm Larsen, A Nissinen, Juha Pekkanen, Sirkka Keinänen‐Kiukaanniemi, Liisa Hiltunen, Sirkka‐Liisa Kivelä, Jaakko Tuomilehto, Pekka Jousilahti, Jaana Lindström, Marja Pyörälä, Kalevi Pyörälà, É. Eschwège, Giuseppe Gallus, Maria Paola Garancini, Anna Schranz, Robert J. Heine, Joost Dekker, Edith J. M. Feskens, Hans Lithell, Björn Zethelius, Markku Peltonen, Nigel Unwin, Nasir Ahmad, K. G. M. M. Alberti, M.M. Alberti, Jane Salier Eriksson, Qing Qiao - The Lancet 1999 cited by 1,273

  24. Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects

    Authors: Per Axel Clausen, Jan Skov Jensen, G Jensen, K. Borch‐Johnsen, Bo Feldt‐Rasmussen - Circulation 2001 cited by 234